
Charanjit Aulakh
Examiner (ID: 2304, Phone: (571)272-0678 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1612, 1625, 1203, 1621 |
| Total Applications | 3771 |
| Issued Applications | 2863 |
| Pending Applications | 382 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17815386
[patent_doc_number] => 11420984
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Arginase inhibitors and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/969739
[patent_app_country] => US
[patent_app_date] => 2019-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 29788
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16969739
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/969739 | Arginase inhibitors and methods of use thereof | Feb 14, 2019 | Issued |
Array
(
[id] => 15227383
[patent_doc_number] => 10501401
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-10
[patent_title] => Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/275165
[patent_app_country] => US
[patent_app_date] => 2019-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43857
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16275165
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/275165 | Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof | Feb 12, 2019 | Issued |
Array
(
[id] => 14963017
[patent_doc_number] => 20190308986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => PROCESS FOR IMPROVED OPIOID SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 16/270969
[patent_app_country] => US
[patent_app_date] => 2019-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16270969
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/270969 | PROCESS FOR IMPROVED OPIOID SYNTHESIS | Feb 7, 2019 | Abandoned |
Array
(
[id] => 14375157
[patent_doc_number] => 20190161491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => METHODS FOR THE CHEMICAL SYNTHESIS OF PYRROLE-LINKED BIVALENT COMPOUNDS, AND COMPOSITIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/265286
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16265286
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/265286 | Methods for the chemical synthesis of pyrrole-linked bivalent compounds, and compositions thereof | Jan 31, 2019 | Issued |
Array
(
[id] => 16628671
[patent_doc_number] => 20210047324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/966176
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31004
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966176
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/966176 | SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF | Jan 30, 2019 | Abandoned |
Array
(
[id] => 15396043
[patent_doc_number] => 10538666
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-21
[patent_title] => Compound, polymer, film, and optical device
[patent_app_type] => utility
[patent_app_number] => 16/263355
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 15031
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 326
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16263355
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/263355 | Compound, polymer, film, and optical device | Jan 30, 2019 | Issued |
Array
(
[id] => 16621442
[patent_doc_number] => 20210040095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/966170
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12334
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966170
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/966170 | Spiro-lactam NMDA receptor modulators and uses thereof | Jan 30, 2019 | Issued |
Array
(
[id] => 14375159
[patent_doc_number] => 20190161492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => PROCESS FOR PREPARING OXYCODONE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/262683
[patent_app_country] => US
[patent_app_date] => 2019-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16262683
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/262683 | Process for preparing oxycodone compositions | Jan 29, 2019 | Issued |
Array
(
[id] => 17022283
[patent_doc_number] => 20210246154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => RUTHENIUM COMPLEX CONTAINING ALKYNYL GROUP, METHOD OF SYNTHESIZING THE SAME AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/050458
[patent_app_country] => US
[patent_app_date] => 2019-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050458
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/050458 | Ruthenium complex containing alkynyl group, method of synthesizing the same and use thereof | Jan 24, 2019 | Issued |
Array
(
[id] => 14581207
[patent_doc_number] => 20190218212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => HETEROARYL COMPOUNDS FOR KINASE INHIBITION
[patent_app_type] => utility
[patent_app_number] => 16/257577
[patent_app_country] => US
[patent_app_date] => 2019-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67931
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16257577
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/257577 | HETEROARYL COMPOUNDS FOR KINASE INHIBITION | Jan 24, 2019 | Abandoned |
Array
(
[id] => 16444843
[patent_doc_number] => 10836755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => Cardiac sarcomere inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/252483
[patent_app_country] => US
[patent_app_date] => 2019-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61209
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16252483
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/252483 | Cardiac sarcomere inhibitors | Jan 17, 2019 | Issued |
Array
(
[id] => 18085487
[patent_doc_number] => 11535604
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Fasoracetam crystalline forms
[patent_app_type] => utility
[patent_app_number] => 16/963494
[patent_app_country] => US
[patent_app_date] => 2019-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 7005
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16963494
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/963494 | Fasoracetam crystalline forms | Jan 16, 2019 | Issued |
Array
(
[id] => 14531513
[patent_doc_number] => 20190201377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF LIPID STORAGE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/247880
[patent_app_country] => US
[patent_app_date] => 2019-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16247880
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/247880 | METHODS AND COMPOSITIONS FOR TREATMENT OF LIPID STORAGE DISORDERS | Jan 14, 2019 | Abandoned |
| 16/317627 | INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7) | Jan 13, 2019 | Abandoned |
Array
(
[id] => 16711802
[patent_doc_number] => 20210078949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => METHODS FOR PREPARATION OF JASMONATE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/960089
[patent_app_country] => US
[patent_app_date] => 2019-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5516
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16960089
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/960089 | Methods for preparation of jasmonate compounds | Jan 5, 2019 | Issued |
Array
(
[id] => 14566733
[patent_doc_number] => 20190210973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => COMPOUNDS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 16/240679
[patent_app_country] => US
[patent_app_date] => 2019-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 335
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16240679
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/240679 | COMPOUNDS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS | Jan 3, 2019 | Abandoned |
Array
(
[id] => 16657342
[patent_doc_number] => 20210053978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => TRICYCLIC INHIBITORS OF THE BCL6 BTB DOMAIN PROTEIN-PROTEIN INTERACTION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/955975
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50567
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -55
[patent_words_short_claim] => 291
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955975
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955975 | Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereof | Dec 20, 2018 | Issued |
Array
(
[id] => 19012987
[patent_doc_number] => 11919902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/956953
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84938
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 634
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956953
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/956953 | Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors | Dec 20, 2018 | Issued |
Array
(
[id] => 18443819
[patent_doc_number] => 11679372
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-20
[patent_title] => Multivariate metal-organic frameworks for fine-tuning light emission
[patent_app_type] => utility
[patent_app_number] => 16/956781
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 16190
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956781
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/956781 | Multivariate metal-organic frameworks for fine-tuning light emission | Dec 20, 2018 | Issued |
Array
(
[id] => 18013257
[patent_doc_number] => 11505539
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Deuterated compounds as inhibitors of the BCL6 BTB domain protein-protein interaction and/or as BCL6 degraders
[patent_app_type] => utility
[patent_app_number] => 16/955998
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15509
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955998
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955998 | Deuterated compounds as inhibitors of the BCL6 BTB domain protein-protein interaction and/or as BCL6 degraders | Dec 20, 2018 | Issued |